These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
65. Arginine methylation inhibits the binding of proline-rich ligands to Src homology 3, but not WW, domains. Bedford MT; Frankel A; Yaffe MB; Clarke S; Leder P; Richard S J Biol Chem; 2000 May; 275(21):16030-6. PubMed ID: 10748127 [TBL] [Abstract][Full Text] [Related]
66. A putative Src homology 3 domain binding motif but not the C-terminal dystrophin WW domain binding motif is required for dystroglycan function in cellular polarity in Drosophila. Yatsenko AS; Gray EE; Shcherbata HR; Patterson LB; Sood VD; Kucherenko MM; Baker D; Ruohola-Baker H J Biol Chem; 2007 May; 282(20):15159-69. PubMed ID: 17355978 [TBL] [Abstract][Full Text] [Related]
67. WW domain-mediated interactions reveal a spliceosome-associated protein that binds a third class of proline-rich motif: the proline glycine and methionine-rich motif. Bedford MT; Reed R; Leder P Proc Natl Acad Sci U S A; 1998 Sep; 95(18):10602-7. PubMed ID: 9724750 [TBL] [Abstract][Full Text] [Related]
68. Cooperative and selective roles of the WW domains of the yeast Nedd4-like ubiquitin ligase Rsp5 in the recognition of the arrestin-like adaptors Bul1 and Bul2. Watanabe D; Murai H; Tanahashi R; Nakamura K; Sasaki T; Takagi H Biochem Biophys Res Commun; 2015 Jul 17-24; 463(1-2):76-81. PubMed ID: 25998383 [TBL] [Abstract][Full Text] [Related]
69. Determinants of ligand specificity in groups I and IV WW domains as studied by surface plasmon resonance and model building. Kato Y; Ito M; Kawai K; Nagata K; Tanokura M J Biol Chem; 2002 Mar; 277(12):10173-7. PubMed ID: 11751914 [TBL] [Abstract][Full Text] [Related]
70. Structural analysis of WW domains and design of a WW prototype. Macias MJ; Gervais V; Civera C; Oschkinat H Nat Struct Biol; 2000 May; 7(5):375-9. PubMed ID: 10802733 [TBL] [Abstract][Full Text] [Related]
71. Aromatic and basic residues within the EVH1 domain of VASP specify its interaction with proline-rich ligands. Carl UD; Pollmann M; Orr E; Gertlere FB; Chakraborty T; Wehland J Curr Biol; 1999 Jul; 9(13):715-8. PubMed ID: 10498433 [TBL] [Abstract][Full Text] [Related]
73. Structural insights into the functional versatility of WW domain-containing oxidoreductase tumor suppressor. Farooq A Exp Biol Med (Maywood); 2015 Mar; 240(3):361-74. PubMed ID: 25662954 [TBL] [Abstract][Full Text] [Related]
74. Solution structure and binding specificity of FBP11/HYPA WW domain as Group-II/III. Kato Y; Hino Y; Nagata K; Tanokura M Proteins; 2006 Apr; 63(1):227-34. PubMed ID: 16463264 [TBL] [Abstract][Full Text] [Related]
75. A single point mutation in a group I WW domain shifts its specificity to that of group II WW domains. Espanel X; Sudol M J Biol Chem; 1999 Jun; 274(24):17284-9. PubMed ID: 10358088 [TBL] [Abstract][Full Text] [Related]
76. Association of two nuclear proteins, Npw38 and NpwBP, via the interaction between the WW domain and a novel proline-rich motif containing glycine and arginine. Komuro A; Saeki M; Kato S J Biol Chem; 1999 Dec; 274(51):36513-9. PubMed ID: 10593949 [TBL] [Abstract][Full Text] [Related]
77. Modulating the folding stability and ligand binding affinity of Pin1 WW domain by proline ring puckering. Tang HC; Lin YJ; Horng JC Proteins; 2014 Jan; 82(1):67-76. PubMed ID: 23839950 [TBL] [Abstract][Full Text] [Related]
78. Allostery mediates ligand binding to WWOX tumor suppressor via a conformational switch. Schuchardt BJ; Mikles DC; Bhat V; McDonald CB; Sudol M; Farooq A J Mol Recognit; 2015 Apr; 28(4):220-31. PubMed ID: 25703206 [TBL] [Abstract][Full Text] [Related]
79. WW or WoW: the WW domains in a union of bliss. Sudol M; Recinos CC; Abraczinskas J; Humbert J; Farooq A IUBMB Life; 2005 Dec; 57(12):773-8. PubMed ID: 16393779 [TBL] [Abstract][Full Text] [Related]